MedTrace Logo

Oxycodone (10, 20 mg) in a Postoperative Dressing

NCT06142591 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-11-21

No results posted yet for this study

Summary

The study mainly focuses on pain management using 10- or 20mg oxycodone burn wound dressing at Poznan University of Medical Sciences.

Conditions

  • Burns

Interventions

DRUG

Oxycodone 10mg

10mg of oxycodone was added to Octenisept in the wound dressing.

DRUG

Oxycodone 20mg

20mg of oxycodone was added to Octenisept in the wound dressing.

Sponsors & Collaborators

  • Poznan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Katarzyna Wieczorowska-Tobis, Prof.dr hab · Poznań University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2018-02-28
Completion
2022-03-03

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06142591 on ClinicalTrials.gov